William John Plovanic
Independent DirectorMr. William John Plovanic, C.F.A., also known as Bill, is Independent Director of TELA Bio, Inc. from October 31, 2025. He serves as the Managing Director of Life Science Research at Canaccord Genuity Corp., Research Division. He has rejoined the Canaccord Genuity. Earlier, Mr. Plovanic served as the Managing Director and Research Analyst at the Canaccord Genuity since February 2007 until March 2016. He covered Medical Technology sector within equity research team at the firm. Prior to that, he served as Chief Executive Officer at Obalon Therapeutics, Inc. from October 19, 2019 until June 19, 2020 and served as its President until June 19, 2020. He serves as Director at Obalon Therapeutics, Inc. since May 20, 2019. Mr. Plovanic served as President and Director of the firm since May 20, 2019 and served as its Secretary. He served as Chief Financial Officer at the firm since March 2016 until October 19, 2019. He joined the firm in March 2016. Mr. Plovanic spent several years as an equity research Analyst for several investment banks and worked with medical device companies that were focused on bringing new technologies and solutions to patients and providers. Earlier, Mr. Plovanic served as Managing Director of Equity Research at First Albany Capital Inc. from February 2001 to February 2007. He was an Equity Analyst at Broadpoint Capital Inc., Research Division, Investec Securities Ltd., Research Division, Gleacher & Company, Inc., Research Division and Hamilton Investments Inc., Research Division. He was employed at Investec Bank Limited (SA), Research Division. He is a CFA charterholder. Mr. Plovanic holds a B.S. degree in finance from Bradley University.
Positions
- Company NameTELA Bio, Inc.Stock CodeTELAPositionIndependent DirectorColleagues
- JBJeffrey BlizardPresident
- JHJoseph H. CapperIndependent Chairman
- HCHeather C. GetzCEO, Principal Financial Officer & Director
- MFMike FarrellSenior Vice President of Finance
- MSMegan SmeykalVP, Corporate Controller, Chief Accounting Officer & Principal Accounting Officer
- PTPaul TalmoChief Science & Innovation Officer
- GPGuy Paul NohraIndependent Director
- PGPaul G. ThomasIndependent Director
